Patients using bisphosphonates to treat osteoporosis could benefit from a ‘drug holiday’ after three to five years of treatment, new US guidelines recommend. The new report by a task force of the American Society for Bone and Mineral Research has been welcomed by Professor Peter Ebeling, head of the department of Medicine at the School ...
Bisphosphonates holiday gets the clinical nod
By Amanda Sheppeard
29 Jan 2016